Literature DB >> 18025701

Molecular inversion probe assay.

Farnaz Absalan, Mostafa Ronaghi.   

Abstract

We have described molecular inversion probe technologies for large-scale genetic analyses. This technique provides a comprehensive and powerful tool for the analysis of genetic variation and enables affordable, large-scale studies that will help uncover the genetic basis of complex disease and explain the individual variation in response to therapeutics. Major applications of the molecular inversion probes (MIP) technologies include targeted genotyping from focused regions to whole-genome studies, and allele quantification of genomic rearrangements. The MIP technology (used in the HapMap project) provides an efficient, scalable, and affordable way to score polymorphisms in case/control populations for genetic studies. The MIP technology provides the highest commercially available multiplexing levels and assay conversion rates for targeted genotyping. This enables more informative, genome-wide studies with either the functional (direct detection) approach or the indirect detection approach.

Mesh:

Substances:

Year:  2007        PMID: 18025701     DOI: 10.1007/978-1-59745-515-2_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

2.  Genome-wide discovery of DNA polymorphism in Brassica rapa.

Authors:  Soomin Park; Hee-Ju Yu; Jeong-Hwan Mun; Seung-Chan Lee
Journal:  Mol Genet Genomics       Date:  2009-12-19       Impact factor: 3.291

3.  Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features.

Authors:  Alyaa Al-Ibraheemi; Anthony Martinez; Sharon W Weiss; Harry P Kozakewich; Antonio R Perez-Atayde; Henry Tran; David M Parham; William R Sukov; Karen J Fritchie; Andrew L Folpe
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

Review 4.  Diagnosing the drug resistance signature in Plasmodium falciparum: a review from contemporary methods to novel approaches.

Authors:  Laxman Kumar Murmu; Arpita Arsmika Sahu; Tapan Kumar Barik
Journal:  J Parasit Dis       Date:  2021-01-07

Review 5.  Genomic approaches for the discovery of genes mutated in inherited retinal degeneration.

Authors:  Anna M Siemiatkowska; Rob W J Collin; Anneke I den Hollander; Frans P M Cremers
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

Review 6.  Finding the fifth base: genome-wide sequencing of cytosine methylation.

Authors:  Ryan Lister; Joseph R Ecker
Journal:  Genome Res       Date:  2009-03-09       Impact factor: 9.043

7.  Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.

Authors:  May P Chan; Aleodor A Andea; Paul W Harms; Alison B Durham; Rajiv M Patel; Min Wang; Patrick Robichaud; Gary J Fisher; Timothy M Johnson; Douglas R Fullen
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

8.  Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Douglas B Flieder; Mona S Jahromi; Joshua D Schiffman; Andrew K Godwin; Margaret von Mehren
Journal:  Genes Chromosomes Cancer       Date:  2012-10-29       Impact factor: 5.006

9.  Long range PCR-based deep sequencing for haplotype determination in mixed HCMV infections.

Authors:  Nadja Brait; Büşra Külekçi; Irene Goerzer
Journal:  BMC Genomics       Date:  2022-01-06       Impact factor: 3.969

10.  Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease.

Authors:  Balaji S Srinivasan; Jaleh Doostzadeh; Farnaz Absalan; Sharareh Mohandessi; Roxana Jalili; Saharnaz Bigdeli; Justin Wang; Jaydev Mahadevan; Caroline L G Lee; Ronald W Davis; J William Langston; Mostafa Ronaghi
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.